THE COVID APOLLO PROJECT

Bringing together leading life sciences investment funds with diagnostics expertise to identify, scale up, and bring to market Covid-19 testing solutions that enable safe return-to-work/school.

To learn more about the program, contact us today.

 
 

Overview

The Covid Apollo Project brings together the expertise and capital necessary to identify, assemble, develop, and scale the most promising Covid-19 testing solutions.

We aim to bring the first of these to market in time for flu season this fall.

Learn More >

 

Partners

Covid Apollo was organized and funded under the leadership of RA Capital, a prominent biotechnology-focused investment firm, in collaboration with peers Redmile Group, Samsara, Perceptive, and Bain.

Our Team >

 
Covid-Apollo-Project-Partner-Bain-Capital.png
Covid-Apollo-Project-Partner-The-Redmile-Group.png
Covid-Apollo-Project-Partner-RA-Capital.png
Covid-Apollo-Project-Partner-Perceptive-Advisors.png
Covid-Apollo-Project-Partner-Samsara-Biocapital.png

Board Of Directors

 
 
Nate Davis.png

Nate Davis
RA Capital

Covid-Apollo-Project-Director-Michael-Altman.jpg

Michael Altman
Perceptive Advisors

highres_1594.jpg

Cory Freedland
Samsara BioCapital

Covid-Apollo-Project-Director-Ben-Lund.jpg

Ben Lund
Bain Capital

Covid-Apollo-Project-Director-Amrit-Nagral.jpg

Amrit Nagpal
Redmile Group

 

Covid Apollo Project

 
 
IMG_2541.jpg

Stefan Willemsen

Chief Executive Officer

 
karwowski_szymon_0495-2.JPG

Szymon Karwowski

Chief Technology and Data Officer